$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.
Sector
Health Technology
CEO
Joseph W. Turgeon
Industry
Biotechnology
Exchange
NAS
Website
Top Stories
Coming soon.